XR Securities’s BioNTech BNTX Stock Holding History

XR Securities’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,000	Closed	-$426K	–	367
2021 Q4	$426K	Buy	7,000 +3,100	+79%	+$849K	0.04%	111
2021 Q3	$418K	Buy	3,900 +1,600	+70%	+$509K	0.19%	105
2021 Q2	$281K	Buy	+2,300	New	+$434K	0.12%	146

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

XR Securities's BNTX Position: Q4 2021 in Review

XR Securities sold out of BioNTech (BNTX) in Q4 2021, closing a stake of 1,879 shares — an estimated $515K sold.

XR Securities first reported a position in BNTX in Q4 2020 and held it in 2 quarters. The position peaked at $667K in Q4 2020. 354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

XR Securities reported no remaining BioNTech position as of Q4 2021 after selling out during the quarter.
XR Securities sold 1,879 BioNTech shares in Q4 2021, an estimated $515K.
XR Securities first reported a position in BioNTech in Q4 2020 and held it in 2 quarters.
XR Securities's BioNTech position peaked at $667K in Q4 2020.
354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on XR Securities's 13F filing for Q4 2021, filed 10 Jan 2022.